CP-154,526
From Infogalactic: the planetary knowledge core
200px | |
Names | |
---|---|
IUPAC name
N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[3,2-e]pyrimidin-4-amine
|
|
Identifiers | |
157286-86-7 | |
ChEMBL | ChEMBL9946 |
ChemSpider | 4470592 |
3495 | |
Jmol 3D model | Interactive image |
PubChem | 5311055 |
|
|
|
|
Properties | |
C23H32N4 | |
Molar mass | 364.52698 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.[1]
CP-154,526 is under investigation for the potential treatment of alcoholism.[2][3]
See also
References
External links
- CP 154526 at the US National Library of Medicine Medical Subject Headings (MeSH)
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Articles without KEGG source
- Articles without UNII source
- Articles with changed InChI identifier
- Pages using collapsible list with both background and text-align in titlestyle
- Chemical articles using a fixed chemical formula
- Anxiolytics
- CRF-1 antagonists
- Pyrrolopyrimidines
- Pfizer
- Nervous system drug stubs